相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Innate lymphoid cells: new insights into function and development
Victor S. Cortez et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients
Katarina Mirjacic Martinovic et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15
Ana M. Vuletic et al.
MELANOMA RESEARCH (2015)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
Jeffrey W. Leong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Advantages and clinical applications of natural killer cells in cancer immunotherapy
Erik Ames et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
NKG2D CARs as Cell Therapy for Cancer
Charles L. Sentman et al.
CANCER JOURNAL (2014)
Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications
Lorenzo Moretta et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2014)
Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients
Katarina M. Mirjacic Martinovic et al.
MELANOMA RESEARCH (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
Killer Immunoglobulin-like Receptors and Tumor Immunity
Don M. Benson et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Complexity and divers y of he NKR-P1:Clr (Klrb1:Clec2) recognition systems
Christina L. Kirkham et al.
FRONTIERS IN IMMUNOLOGY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
Rizwan Romee et al.
BLOOD (2013)
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
Nathalie Fiegler et al.
BLOOD (2013)
Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity
Katrin S. Reiners et al.
BLOOD (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
Natural killer cell biology: An update and future directions
Kerry S. Campbell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients
Ana Vuletic et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation
Sisi He et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer
Yun-Peng Peng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
G. Chitadze et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Combination immune therapies to enhance anti-tumor responses by NK cells
Ashley Mentlik James et al.
FRONTIERS IN IMMUNOLOGY (2013)
Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells
Kelly Hudspeth et al.
FRONTIERS IN IMMUNOLOGY (2013)
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies
Ursula J. E. Seidel et al.
FRONTIERS IN IMMUNOLOGY (2013)
The tumor microenvironment: a pitch for multiple players
Giovanna Schiavoni et al.
FRONTIERS IN ONCOLOGY (2013)
Shaping of NK Cell Responses by the Tumor Microenvironment
Ana Stojanovic et al.
CANCER MICROENVIRONMENT (2013)
Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor
Elisa Montaldo et al.
BLOOD (2012)
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
Esther M. de Kruijf et al.
BMC CANCER (2012)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma
Silke Heidenreich et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Investigation of NK cell function and their modulation in different malignancies
Gordana Konjevic et al.
IMMUNOLOGIC RESEARCH (2012)
HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression
Celine Bossard et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
When NK cells overcome their lack of education
Baptiste N. Jaeger et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
Jing Ni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tuning of Natural Killer Cell Reactivity by NKp46 and Helios Calibrates T Cell Responses
Emilie Narni-Mancinelli et al.
SCIENCE (2012)
Identification and Functional Analysis of Ligands for Natural Killer Cell Activating Receptors in Colon Carcinoma
Zhang Zhang et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2012)
A novel mechanism for cancer cells to evade immune attack by NK cells The interaction between NKp44 and proliferating cell nuclear antigen
Benyamin Rosental et al.
ONCOIMMUNOLOGY (2012)
Clinical Significance of the HLA-E and CD94/NKG2 Interaction
Milena Iwaszko et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)
Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1
Yuk Pheel Park et al.
BLOOD (2011)
Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands
Beatriz Sanchez-Correa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition
Emilie Mamessier et al.
CANCER RESEARCH (2011)
Regulation of immune cell function and differentiation by the NKG2D receptor
Biljana Zafirova et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer
Suliman Y. Al Omar et al.
IMMUNOLOGY (2011)
Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations
Kerry S. Campbell et al.
IMMUNOLOGY (2011)
Activating and inhibitory receptors of natural killer cells
Hollie J. Pegram et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44
Benyamin Rosental et al.
JOURNAL OF IMMUNOLOGY (2011)
NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions
Sara Morgado et al.
JOURNAL OF INNATE IMMUNITY (2011)
The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients
Katarina Mirjacic Martinovic et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance
Sophie Guia et al.
SCIENCE SIGNALING (2011)
Cytokine regulation of natural killer cell effector functions
Norberto W. Zwirner et al.
BIOFACTORS (2010)
Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction
G. Konjevic et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
Sandra Lopez-Verges et al.
BLOOD (2010)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
Sorafenib Inhibits the Shedding of Major Histocompatibility Complex Class I-Related Chain A on Hepatocellular Carcinoma Cells by Down-Regulating a Disintegrin and Metalloproteinase 9
Keisuke Kohga et al.
HEPATOLOGY (2010)
In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients
Gordana Konjevic et al.
MELANOMA RESEARCH (2010)
Current perspectives of natural killer cell education by MHC class I molecules
Petter Hoeglund et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3-CD16+NK cells
Gordana Konjevic et al.
BIOMARKERS (2009)
Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
Trinidad Garcia-Iglesias et al.
BMC CANCER (2009)
An integrated view of the regulation of NKG2D ligands
Noam Stern-Ginossar et al.
IMMUNOLOGY (2009)
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Tadepally Lakshmikanth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Distribution of Several Activating and Inhibitory Receptors on CD3-CD16+ NK Cells and Their Correlation with NK Cell Function in Healthy Individuals
Gordana Konjevic et al.
JOURNAL OF MEMBRANE BIOLOGY (2009)
Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses
William H. D. Hallett et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
The NKG2D receptor: sensing stressed cells
Carlos Lopez-Larrea et al.
TRENDS IN MOLECULAR MEDICINE (2008)
CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma
G. Konjevi et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease
R. J. Boyton et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
Jeffery S. Miller et al.
BLOOD (2007)
Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors
Mmberly A. Varker et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Donor-recipient combinations of group A and BKIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation
Karina L. McQueen et al.
HUMAN IMMUNOLOGY (2007)
Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component
K. C. Hsu et al.
TISSUE ANTIGENS (2007)
Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients
Gordana Konjevic et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases
B. Grzywacz et al.
LEUKEMIA (2007)
Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma
Elissaveta Naumova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients
Jose A. Campillo et al.
CLINICAL CANCER RESEARCH (2006)
Human natural killer cell development and biology
Sherif S. Farag et al.
BLOOD REVIEWS (2006)
Evidence for discrete stages of human natural killer cell differentiation in vivo
AG Freud et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction
D Pende et al.
BLOOD (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
NKG2D and cytotoxic effector function in tumor immune surveillance
Yoshihiro Hayakawa et al.
SEMINARS IN IMMUNOLOGY (2006)
Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor
DB Rosen et al.
JOURNAL OF IMMUNOLOGY (2005)
Cutting edge: Lectin-like transcript 1 is a ligand for the CD161 receptor
H Aldemir et al.
JOURNAL OF IMMUNOLOGY (2005)
Natural killer cell signaling pathways
E Vivier et al.
SCIENCE (2004)
Natural killer cell receptor signaling
LL Lanier
CURRENT OPINION IN IMMUNOLOGY (2003)
A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition
J Michaëlsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
NK cells: a lesson from mismatched hematopoietic transplantation
A Velardi et al.
TRENDS IN IMMUNOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset
MA Cooper et al.
BLOOD (2001)
分享论文
